HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Bart Sangal Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

7/2015Use of EEG Beta-1 Power and Theta/Beta Ratio Over Broca's Area to confirm Diagnosis of Attention Deficit/Hyperactivity Disorder in Children.
10/2014Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
6/2012A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
10/2007Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
12/2006Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
12/2006Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
9/2006Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
5/2006A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.
3/2005Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine.
11/2004A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Bart Sangal Research Topics

Disease

13Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2015 - 11/2002
5Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 05/2006
4Obstructive Sleep Apnea
10/2023 - 12/2012
3Fatigue
10/2023 - 12/2012
2Apnea
10/2023 - 12/2012
2Sleep Wake Disorders
10/2023 - 12/2012
2Sleepiness
05/2020 - 12/2012
2Headache (Headaches)
10/2014 - 05/2006
1Sleep Apnea Syndromes (Sleep Apnea)
07/2018
1Dizziness (Lightheadedness)
10/2014
1Dysgeusia (Parageusia)
10/2014
1Narcolepsy
12/2012
1Albuminuria
01/2009
1Weight Loss (Weight Reduction)
05/2006

Drug/Important Bio-Agent (IBA)

7Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2023 - 11/2002
6Methylphenidate (Ritalin)FDA LinkGeneric
12/2006 - 01/2004
2Acetaminophen (Paracetamol)FDA LinkGeneric
10/2020 - 05/2020
2Pemoline (Cylert)FDA Link
03/2005 - 01/2004
2Dexmethylphenidate HydrochlorideFDA LinkGeneric
11/2004 - 01/2004
1Mirtazapine (Rexer)FDA LinkGeneric
01/2021
1Hypnotics and Sedatives (Sedatives)IBA
07/2018
1suvorexantIBA
01/2016
1Orexin Receptor AntagonistsIBA
01/2016
1Eszopiclone (Lunesta)FDA Link
10/2014
1pozaniclineIBA
06/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2012
1CreatinineIBA
01/2009
1TabletsIBA
05/2006
1Modafinil (Provigil)FDA Link
05/2006

Therapy/Procedure

3Continuous Positive Airway Pressure
10/2023 - 12/2012
1Electrodes (Electrode)
07/2015